Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Bax deficiency affects caspase-2 activation during ultraviolet radiation-induced apoptosis

Abstract

There has been a considerable debate as to whether caspase-2 is an initiator or effector caspase. Recently, a new model of intrinsic pathway of apoptosis has been proposed, which suggests caspase-2 to be an initiator caspase. For example, ultraviolet radiation (UV) and other DNA damage-inducing agents were shown to first activate caspase-2 and then regulate the mitochondrial and postmitochondrial events. Active caspase-2 was found to engage mitochondria by promoting Bax translocation to the mitochondria. Consequently, Bax was proposed to play a central role in bridging the active caspase-2 with mitochondria by affecting mitochondrial permeability, cytochrome c release into the cytosol and caspase-9 activation. In the present study, we investigated the role of Bax in UV-induced apoptosis and caspase-2 activation. Our results indicate that UV-induced apoptosis and caspase-2 activation were diminished in Bax-deficient cells, suggesting that Bax appears to play an important role in UV-induced apoptosis as well as caspase-2 activation, and that it also appears to reside upstream of caspase-2. Bax deficiency also affected the activation of caspase-3 and -8 and abolished caspase-9 activation during UV-induced apoptosis, suggesting that the absence of caspase-9 activation may affect caspase-2, -3 and -8 activation in Bax-deficient cells. Based on our results, we propose that activation of caspases is not a linear cascade of events, but is rather connected via complex feedback loops.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Aragane Y, Klums D, Metze D, Wikes G, Poppelmann B, Luger TA and Schwarz T . (1998). J. Cell Biol., 140, 171–182.

  • Ashkenazi A and Dixit VM . (1999). Curr. Opin. Cell Biol., 11, 255–260.

  • Cowling V and Downward J . (2002). Cell Death Differ., 9, 1046–1056.

  • Fujita E, Egashira J, Urase K, Kuida K and Momoi T . (2001). Cell Death Differ., 8, 335–344.

  • Gross A, McDonnell JM and Korsmeyer SJ . (2000). Genes Dev., 13, 1899–1911.

  • Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T and Alnemri ES . (2002). J. Biol. Chem., 277, 13430–134307.

  • Harvey NL, Butt AJ and Kumar S . (1997). J. Biol. Chem., 272, 13134–13139.

  • He Q, Luo X, Huang Y and Sheikh MS . (2002). Oncogene, 21, 6032–6040.

  • Hengartner MO . (2000). Nature, 407, 770–776.

  • Holcik M and Korneluk RG . (2001). Nat. Rev. Mol. Cell Biol., 2, 550–556.

  • Huang Y, He Q, Hillman MJ, Rong R and Sheikh MS . (2001). Cancer Res., 61, 6918–6924.

  • Lassus P, Opitz-Araya X and Lazebnik Y . (2002). Science, 297, 1352–1354.

  • Li H, Bergeron L, Cryns V, Pasternack MS, Zhu H, Shi L, Greenberg A and Yuan J . (1997). J. Biol. Chem., 272, 21010–21017.

  • Paroni G, Henderson C, Schneider C and Brancolini C . (2001). J. Biol. Chem., 276, 21907–21915.

  • Rehemtulla A, Hamilton CA, Chinnaiyan AM and Dixit VM . (1997). J. Biol. Chem., 272, 25783–257836.

  • Robertson JD, Enoksson M, Suomela M, Zhivotovsky B and Orrenius S . (2002). J. Biol. Chem., 2002277, 29803–29809.

  • Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S and Peter ME . (1998). Eur. J. Biochem., 254, 439–459.

  • Sheikh MS, Antinore MJ, Huang Y and Fornace Jr AJ . (1998). Oncogene, 17, 2555–2563.

  • Sheikh MS and Fornace Jr AJ . (2000). J. Cell. Physiol., 182, 171–181.

  • Sitailo LA, Tibudan SS and Denning MF . (2002). J. Biol. Chem., 277, 19346–19352.

  • Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ . (1999). J. Cell Biol., 144, 281–292.

  • Thornberry NA and Lazebnik Y . (1998). Science, 281, 1312–1316.

  • Wang L, Miura M, Bergeron L, Zhu H and Yuan J . (1994). Cell., 78, 739–750.

  • Wang X . (2001). Genes Dev., 15, 2922–2933.

  • Zhang L, Yu J, Park BH, Kinzler KW and Vogelstein B . (2000). Science, 290, 989–992.

Download references

Acknowledgements

We thank Dr Bert Vogelstein (Johns Hopkins University, Baltimore, MD), for kindly providing the Bax-proficient and -deficient cells used in this study. This work was supported in part by NIH grants CA89043, CA86945 and a Department of Defense grant DMAD 170010722.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Saeed Sheikh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

He, Q., Huang, Y. & Sheikh, M. Bax deficiency affects caspase-2 activation during ultraviolet radiation-induced apoptosis. Oncogene 23, 1321–1325 (2004). https://doi.org/10.1038/sj.onc.1207212

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207212

Keywords

This article is cited by

Search

Quick links